0001127602-23-015939.txt : 20230517 0001127602-23-015939.hdr.sgml : 20230517 20230517163132 ACCESSION NUMBER: 0001127602-23-015939 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230517 DATE AS OF CHANGE: 20230517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lingamneni Anila CENTRAL INDEX KEY: 0001808414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 23932213 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0401 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-05-15 0000313143 HAEMONETICS CORP HAE 0001808414 Lingamneni Anila 125 SUMMER STREET BOSTON MA 02110 1 EVP, Chief Technology Officer 0 Common Stock 2023-05-15 4 A 0 3364 A 20807 D Common Stock 2023-05-16 4 F 0 318 89.21 D 20489 D Non-qualified Stock Option (Right to Buy) 89.16 2023-05-15 4 A 0 7602 0 A 2030-05-15 Common Stock 7602 7602 D The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. This number includes unvested RSUs previously reported as well as 297 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 28, 2023. Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I. Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Ms. Lingamneni 2023-05-17